UK Markets close in 20 mins

Boston Scientific Corporation (BSX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
37.83+0.17 (+0.46%)
As of 11:09AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 347.50
52-week low 334.98
50-day moving average 339.32
200-day moving average 342.05

Share statistics

Avg vol (3-month) 38.8M
Avg vol (10-day) 37.23M
Shares outstanding 51.42B
Implied shares outstanding 6N/A
Float 81.42B
% held by insiders 10.24%
% held by institutions 192.80%
Shares short (28 Apr 2022) 412.35M
Short ratio (28 Apr 2022) 41.4
Short % of float (28 Apr 2022) 40.87%
Short % of shares outstanding (28 Apr 2022) 40.86%
Shares short (prior month 30 Mar 2022) 415.67M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 305 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 6.66%
Operating margin (ttm)17.58%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)12.16B
Revenue per share (ttm)8.54
Quarterly revenue growth (yoy)10.00%
Gross profit (ttm)8.24B
EBITDA 3.24B
Net income avi to common (ttm)755M
Diluted EPS (ttm)0.77
Quarterly earnings growth (yoy)-67.70%

Balance sheet

Total cash (mrq)1.92B
Total cash per share (mrq)1.35
Total debt (mrq)9.53B
Total debt/equity (mrq)57.30
Current ratio (mrq)N/A
Book value per share (mrq)11.55

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A